Figure S1 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors

<p>Supplemental Figure S1: Expression of CLDN6 by transcript in the GTEX dataset of normal tissue samples.</p>

Tallennettuna:
Bibliografiset tiedot
Päätekijä: Martina S.J. McDermott (15206951) (author)
Muut tekijät: Neil A. O'Brien (15206954) (author), Benjamin Hoffstrom (15206957) (author), KeWei Gong (15206960) (author), Ming Lu (15206963) (author), Jun Zhang (15206966) (author), Tong Luo (15206969) (author), Min Liang (15206972) (author), Weiping Jia (15206975) (author), Jenny J. Hong (15206978) (author), Kevin Chau (15206981) (author), Simon Davenport (15206984) (author), Bin Xie (15206987) (author), Michael F. Press (15206990) (author), Richard Panayiotou (15206993) (author), Abram Handly-Santana (15206996) (author), Joan S. Brugge (9710515) (author), Leonard Presta (15206999) (author), John Glaspy (15207002) (author), Dennis J. Slamon (15047067) (author)
Julkaistu: 2025
Aiheet:
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
_version_ 1849927633719001089
author Martina S.J. McDermott (15206951)
author2 Neil A. O'Brien (15206954)
Benjamin Hoffstrom (15206957)
KeWei Gong (15206960)
Ming Lu (15206963)
Jun Zhang (15206966)
Tong Luo (15206969)
Min Liang (15206972)
Weiping Jia (15206975)
Jenny J. Hong (15206978)
Kevin Chau (15206981)
Simon Davenport (15206984)
Bin Xie (15206987)
Michael F. Press (15206990)
Richard Panayiotou (15206993)
Abram Handly-Santana (15206996)
Joan S. Brugge (9710515)
Leonard Presta (15206999)
John Glaspy (15207002)
Dennis J. Slamon (15047067)
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Martina S.J. McDermott (15206951)
Neil A. O'Brien (15206954)
Benjamin Hoffstrom (15206957)
KeWei Gong (15206960)
Ming Lu (15206963)
Jun Zhang (15206966)
Tong Luo (15206969)
Min Liang (15206972)
Weiping Jia (15206975)
Jenny J. Hong (15206978)
Kevin Chau (15206981)
Simon Davenport (15206984)
Bin Xie (15206987)
Michael F. Press (15206990)
Richard Panayiotou (15206993)
Abram Handly-Santana (15206996)
Joan S. Brugge (9710515)
Leonard Presta (15206999)
John Glaspy (15207002)
Dennis J. Slamon (15047067)
author_role author
dc.creator.none.fl_str_mv Martina S.J. McDermott (15206951)
Neil A. O'Brien (15206954)
Benjamin Hoffstrom (15206957)
KeWei Gong (15206960)
Ming Lu (15206963)
Jun Zhang (15206966)
Tong Luo (15206969)
Min Liang (15206972)
Weiping Jia (15206975)
Jenny J. Hong (15206978)
Kevin Chau (15206981)
Simon Davenport (15206984)
Bin Xie (15206987)
Michael F. Press (15206990)
Richard Panayiotou (15206993)
Abram Handly-Santana (15206996)
Joan S. Brugge (9710515)
Leonard Presta (15206999)
John Glaspy (15207002)
Dennis J. Slamon (15047067)
dc.date.none.fl_str_mv 2025-11-25T13:00:38Z
dc.identifier.none.fl_str_mv 10.1158/1078-0432.30706664
dc.relation.none.fl_str_mv https://figshare.com/articles/figure/Figure_S1_from_Preclinical_Efficacy_of_the_Antibody_Drug_Conjugate_CLDN6_23-ADC_for_the_Treatment_of_CLDN6-Positive_Solid_Tumors/30706664
dc.rights.none.fl_str_mv CC BY
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Cancer
Therapeutic Research and Development
Biological Agents & Therapies
Antibody-drug conjugates
Gynecological Cancers
Endometrial cancer
Ovarian cancer
Translational Research
dc.title.none.fl_str_mv Figure S1 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
dc.type.none.fl_str_mv Image
Figure
info:eu-repo/semantics/publishedVersion
image
description <p>Supplemental Figure S1: Expression of CLDN6 by transcript in the GTEX dataset of normal tissue samples.</p>
eu_rights_str_mv openAccess
id Manara_b46b5d277d28b24597fe6c3d3214c89c
identifier_str_mv 10.1158/1078-0432.30706664
network_acronym_str Manara
network_name_str ManaraRepo
oai_identifier_str oai:figshare.com:article/30706664
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY
spelling Figure S1 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid TumorsMartina S.J. McDermott (15206951)Neil A. O'Brien (15206954)Benjamin Hoffstrom (15206957)KeWei Gong (15206960)Ming Lu (15206963)Jun Zhang (15206966)Tong Luo (15206969)Min Liang (15206972)Weiping Jia (15206975)Jenny J. Hong (15206978)Kevin Chau (15206981)Simon Davenport (15206984)Bin Xie (15206987)Michael F. Press (15206990)Richard Panayiotou (15206993)Abram Handly-Santana (15206996)Joan S. Brugge (9710515)Leonard Presta (15206999)John Glaspy (15207002)Dennis J. Slamon (15047067)CancerTherapeutic Research and DevelopmentBiological Agents & TherapiesAntibody-drug conjugatesGynecological CancersEndometrial cancerOvarian cancerTranslational Research<p>Supplemental Figure S1: Expression of CLDN6 by transcript in the GTEX dataset of normal tissue samples.</p>2025-11-25T13:00:38ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1158/1078-0432.30706664https://figshare.com/articles/figure/Figure_S1_from_Preclinical_Efficacy_of_the_Antibody_Drug_Conjugate_CLDN6_23-ADC_for_the_Treatment_of_CLDN6-Positive_Solid_Tumors/30706664CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307066642025-11-25T13:00:38Z
spellingShingle Figure S1 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
Martina S.J. McDermott (15206951)
Cancer
Therapeutic Research and Development
Biological Agents & Therapies
Antibody-drug conjugates
Gynecological Cancers
Endometrial cancer
Ovarian cancer
Translational Research
status_str publishedVersion
title Figure S1 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
title_full Figure S1 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
title_fullStr Figure S1 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
title_full_unstemmed Figure S1 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
title_short Figure S1 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
title_sort Figure S1 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
topic Cancer
Therapeutic Research and Development
Biological Agents & Therapies
Antibody-drug conjugates
Gynecological Cancers
Endometrial cancer
Ovarian cancer
Translational Research